Anthony Martinelli is founder and Editor-in-Chief of The Marijuana Herald. Anthony previously served as Editor-in-Chief of TheJointBlog.com, and he has worked as a campaign manager and communications director for multiple political campaigns. You can reach Anthony at Info@TheMarijuanaHerald.com.
Anthony Martinelli
Author's posts
Maine Marijuana Sales in February Match Last Year’s Total Despite Prices Down 12%
Maine’s recreational marijuana market generated $17,752,264 in sales in February, nearly identical to the roughly $17.8 million sold in February 2025, despite prices falling sharply over the past year.
Study: Exosome-Based Oral CBD Slows Aggressive Triple-Negative Breast Cancer
A study published in Cancer Letters by researchers from the University of Louisville found that a specially designed oral CBD formulation significantly improved tumor targeting and slowed the growth of aggressive triple-negative breast cancer in mice, while also altering the activity of more than 1,000 genes tied to cancer progression.
Anchorage Marijuana Sales Top $105 Million in 2025
Marijuana sales in Anchorage reached $105,427,131 in 2025 in 2025, generating $5,271,357 in local marijuana retail sales tax. The figures show Anchorage remained a major marijuana market throughout the year, with monthly sales never dropping below $8.1 million.
Tennessee House Majority Leader Says Federal Rescheduling Could Help Open Door to Medical Marijuana Legalization
Federal marijuana rescheduling could help lay the groundwork for the legalization of medical cannabis in Tennessee, according to House Majority Leader William Lamberth (R), one of the clearest signs yet that some Republican lawmakers are becoming more open to change.
Study: Hemp Seed Compounds Show Potential for Treating Diabetes and Obesity
Two naturally occurring compounds derived from hemp seed hulls can help improve blood sugar control and restore key metabolic functions tied to diabetes and obesity, according to a new study published in Phytomedicine.
Georgia Lawmakers Introduce Resolution Urging Marijuana Rescheduling to Schedule III
A group of Georgia lawmakers introduced a resolution this week urging the federal government to move marijuana from Schedule I to Schedule III under federal law.
Study: CBD-Derived Compound Shows Potential to Treat Bladder Dysfunction After Spinal Cord Injury
A new study published in Life Sciences found that a cannabidiol-derived compound may help treat bladder dysfunction caused by spinal cord injury by reducing neuroinflammation and helping restore damaged nerve pathways.
CBD May Counter Meth-Induced Psychosis Symptoms by Protecting Brain Cells, Reports Study
A new study published in Phytomedicine reports that cannabidiol (CBD) may help reduce anxiety-like behavior, memory problems and brain cell damage caused by methamphetamine exposure.
Study: CBD Reduces Inflammatory Pain While Improving Anxiety, Depression and Cognitive Symptoms
A study published today by the journal Brain Research Bulletin found that CBD can help treat not only inflammatory pain, but also some of the anxiety, depression, and cognitive symptoms that can come with chronic pain.
Massachusetts Regulators Extend Delivery Exclusivity for Three More Years, Expands Secret Shopper Program
The Massachusetts Cannabis Control Commission voted unanimously today to make regulatory changes that will extend the exclusivity period for delivery licenses through April 2029 and “improve the Secret Shopper off-the-shelf testing program.”
